CLINICAL_TRIALS trial_result · 2019-10-25

Clinical Trial Update: Study of the Efficacy and Safety of MEDI4893 [Phase 2]

A Phase 2 clinical trial evaluating MEDI4893 for efficacy and safety in Staphylococcus aureus pneumonia has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: MedImmune LLC | Conditions: Staphylococcus Aureus Pneumonia | Phase 2 | Status: COMPLETED | Results posted: 2019-10-25